Parenteral Drugs (India) Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
- Paid Up Capital ₹ 29.82 Cr
- Company Age 41 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 547.55 Cr
- Satisfied Charges ₹ 96.32 Cr
- Revenue Growth -61.93%
- Profit Growth -6.70%
- Ebitda 19.83%
- Net Worth -21.65%
- Total Assets 2.97%
About Parenteral Drugs (India)
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
Industry
Who are the key members and board of directors at Parenteral Drugs (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Gupta
|
Managing Director | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Manohar Gupta
|
Director | 13-Dec-1983 | Current |
|
Dharam Khanna
|
Director | Current | |
|
Dilip Sinha
|
Director | 31-Jan-2006 | Current |
|
Manish Verma
|
Director | Current | |
|
Chhaya Gupta
|
Director | Current | |
|
Govind Garg
|
Whole-Time Director | Current |
Financial Performance of Parenteral Drugs (India).
Parenteral Drugs (India) Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 61.93% decrease. The company also saw a slight decrease in profitability, with a 6.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parenteral Drugs (India)?
In 2021, Parenteral Drugs (India) had a promoter holding of 73.28% and a public holding of 26.73%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹547.55 Cr
₹96.32 Cr
Charges Breakdown by Lending Institutions
- Others : 547.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Apr 2015 | Others | ₹95.63 Cr | Open |
| 21 Dec 2012 | Others | ₹56.50 Cr | Open |
| 26 Sep 2007 | Others | ₹15.28 Cr | Open |
| 26 Sep 2007 | Others | ₹5.80 M | Open |
| 12 Mar 2007 | Others | ₹7.60 M | Open |
How Many Employees Work at Parenteral Drugs (India)?
Parenteral Drugs (India) has a workforce of 610 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parenteral Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parenteral Drugs (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
